Low frequency mutations independently predict poor treatment-free survival in early stage chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis

Haematologica. 2015 Jun;100(6):e237-9. doi: 10.3324/haematol.2014.120238. Epub 2015 Feb 20.
No abstract available

Keywords: early stage chronic lymphocytic leukemia; low frequency mutations; monoclonal B-cell lymphocytosis; treatment-free survival.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • B-Lymphocytes* / pathology
  • Cohort Studies
  • Female
  • Humans
  • Leukemia, Lymphocytic, Chronic, B-Cell / diagnosis*
  • Leukemia, Lymphocytic, Chronic, B-Cell / genetics*
  • Leukemia, Lymphocytic, Chronic, B-Cell / mortality
  • Lymphocytosis / diagnosis*
  • Lymphocytosis / genetics*
  • Lymphocytosis / mortality
  • Male
  • Mutation / genetics*
  • Predictive Value of Tests
  • Survival Rate / trends
  • Treatment Outcome